Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery

Non‐alcoholic fatty liver disease (NAFLD) is a serious global public health concern. Nevertheless, there are no specific medications for treating the associated abnormal accumulation of hepatic lipids such as cholesterol and triglycerides. While seminal findings suggest a link between hepatic choles...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyoda, Yu, Takada, Tappei, Umezawa, Masakazu, Tomura, Fumiya, Yamanashi, Yoshihide, Takeda, Ken, Suzuki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996404/
https://www.ncbi.nlm.nih.gov/pubmed/32123832
http://dx.doi.org/10.1096/fba.2018-00044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996404/
https://www.ncbi.nlm.nih.gov/pubmed/32123832
http://dx.doi.org/10.1096/fba.2018-00044

Ejemplares similares